Nadia Ovchinsky, MD: IBAT Inhibitors for Alagille Syndrome

An emerging drug class is proving viable for burdensome symptoms, as well as liver failure, in pediatric patients with the rare inherited disease.

Related Keywords

,Nadia Ovchinsky ,Grossman School Of Medicine ,